DocMorris AG (ZRSEF) Q2 2026 Earnings Call Transcript

Welcome, everybody, to our H1 '26 results conference call. Today with me is Daniel, our CFO; and I'm Walter Hess, the CEO. The first half of '26 has been a milestone period for DocMorris, marked by accelerated growth and an outstanding operational execution. Our focus remains on scaling our integrated digital and AI-driven health care platform to deliver long-term profitable value. Today's agenda foresees the highlights of H1 to start with, followed by the business update, financial update and the outlook before we move then to the Q&A session. Let's start with our highlights on Slide #4. We delivered a 38% Rx growth in H1, accelerating further to 46% in Q2 with an even stronger momentum continuing into July and August. Our active customer base expanded by 1.1 million year-over-year to 12.9 million with TeleClinic contributing 1.5 million active users. Digital Services grew 71% in H1 and even 80% in Q2, translating directly into an over-proportionate profit increase due to the high margins. The execution of our AI-First strategy is fully on track, expecting a positive earnings contribution in H2 '26 and over CHF 15 million in recurring annual net savings by end of '27. And therefore, on the back of this strong commercial momentum, we have confidently raised our full year '26 financial guidance. DocMorris has successfully transitioned into a